Importantly, the DPP4 inhibitor linagliptin induced a reciprocal decrease in M1 macrophages and an increase in M2 macrophages in white adipose tissue and liver tissue of mice, resulting in attenuation of obesity-induced inflammation and insulin resistance [77]. The gene discussed is DPP4; the disease is obesity due to melanocortin 4 receptor deficiency.